{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:48:59Z","timestamp":1788540539058,"version":"build-2803163510"},"reference-count":28,"publisher":"WHO Press","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. World Health Organ."],"published-print":{"date-parts":[[2014,11,1]]},"DOI":"10.2471\/blt.13.126532","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T08:33:37Z","timestamp":1414139617000},"page":"798-806","source":"Crossref","is-referenced-by-count":13,"title":["Drug resistance of<i>Mycobacterium tuberculosis<\/i>in Malawi: a cross-sectional survey"],"prefix":"10.2471","volume":"92","author":[{"given":"Michael","family":"Abouyannis","sequence":"first","affiliation":[{"name":"Centre for Applied Health Research & Delivery, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Dacombe","sequence":"additional","affiliation":[{"name":"Centre for Applied Health Research & Delivery, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaias","family":"Dambe","sequence":"additional","affiliation":[{"name":"National Tuberculosis Control Programme, Lilongwe, Malawi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mpunga","sequence":"additional","affiliation":[{"name":"National Tuberculosis Control Programme, Lilongwe, Malawi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Faragher","sequence":"additional","affiliation":[{"name":"Centre for Applied Health Research & Delivery, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Gausi","sequence":"additional","affiliation":[{"name":"National Tuberculosis Control Programme, Lilongwe, Malawi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Ndhlovu","sequence":"additional","affiliation":[{"name":"Research for Equity and Community Health Trust, Lilongwe, Malawi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chifundo","family":"Kachiza","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Assistance Programme, Management Sciences for Health, Lilongwe, Malawi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Suarez","sequence":"additional","affiliation":[{"name":"Management Sciences for Health, Arlington, United States of America."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mundy","sequence":"additional","affiliation":[{"name":"Management Sciences for Health, Arlington, United States of America."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hastings T","family":"Banda","sequence":"additional","affiliation":[{"name":"Research for Equity and Community Health Trust, Lilongwe, Malawi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishmael","family":"Nyasulu","sequence":"additional","affiliation":[{"name":"World Health Organization, Lilongwe, Malawi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Bertel","family":"Squire","sequence":"additional","affiliation":[{"name":"Centre for Applied Health Research & Delivery, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, England."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1305","published-online":{"date-parts":[[2014,9,18]]},"reference":[{"issue":"23","key":"key-10.2471\/BLT.13.126532-201410241033-R1","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199806043382301","article-title":"Global surveillance for antituberculosis-drug resistance, 1994\u20131997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.","volume":"338","author":"Pablos-M\u00e9ndez","year":"1998","journal-title":"N Engl J Med"},{"key":"key-10.2471\/BLT.13.126532-201410241033-R2","unstructured":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): 2010 global report on surveillance and response. Geneva: World Health Organization; 2010. Available from: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599191_eng.pdf [cited 2014 Aug 26]."},{"issue":"2","key":"key-10.2471\/BLT.13.126532-201410241033-R3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2471\/BLT.11.092585","article-title":"Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007\u20132010.","volume":"90","author":"Zignol","year":"2012","journal-title":"Bull World Health Organ"},{"key":"key-10.2471\/BLT.13.126532-201410241033-R4","unstructured":"Global tuberculosis control 2011. Geneva: World Health Organization; 2011. Available from: http:\/\/www.who.int\/tb\/publications\/global_report\/2011\/gtbr11_full.pdf [cited 2014 Aug 26]."},{"issue":"1","key":"key-10.2471\/BLT.13.126532-201410241033-R5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3201\/eid1801.110850","article-title":"High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009\u20132010.","volume":"18","author":"Sanchez-Padilla","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"key-10.2471\/BLT.13.126532-201410241033-R6","unstructured":"Dacombe RJ, Samuti G, Dambe I, Mundy C, Suarez PG, Squire SB, et al. Addressing challenges in preparing the TB Central Reference Laboratory, Malawi, for a national drug resistance survey. In: 41st Union World Conference on Lung Health; 2010 Nov 11\u201315; Berlin, Germany. Paris: The International Union Against Tuberculosis and Lung Disease; 2010."},{"issue":"8","key":"key-10.2471\/BLT.13.126532-201410241033-R7","first-page":"752","article-title":"Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986\u20131998.","volume":"4","author":"Warndorff","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.2471\/BLT.13.126532-201410241033-R8","author":"Malawi National TB Control Programme","year":"2007","journal-title":"Manual of the National Tuberculosis Control Programme in Malawi."},{"issue":"9441","key":"key-10.2471\/BLT.13.126532-201410241033-R9","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/S0140-6736(04)17141-9","article-title":"Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.","volume":"364","author":"Jindani","year":"2004","journal-title":"Lancet"},{"issue":"s1","key":"key-10.2471\/BLT.13.126532-201410241033-R10","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1086\/518665","article-title":"HIV infection and multidrug-resistant tuberculosis: the perfect storm.","volume":"196","author":"Wells","year":"2007","journal-title":"J Infect Dis"},{"issue":"9547","key":"key-10.2471\/BLT.13.126532-201410241033-R11","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"key-10.2471\/BLT.13.126532-201410241033-R12","unstructured":"Treatment of tuberculosis guidelines. 4th ed. Geneva: World Health Organization; 2009. Available from: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241547833_eng.pdf?ua=1 [cited 2014 Aug 26]."},{"key":"key-10.2471\/BLT.13.126532-201410241033-R13","unstructured":"Technical guide. Sputum examination for tuberculosis by direct microscopy in low income countries. 5th ed. Paris: International Union Against Tuberculosis and Lung Disease; 2000. Available from: http:\/\/www.uphs.upenn.edu\/bugdrug\/antibiotic_manual\/IUATLD_afb%20microscopy_guide.pdf [cited 2014 Aug 26]."},{"key":"key-10.2471\/BLT.13.126532-201410241033-R14","author":"De Kantor","year":"1998","journal-title":"Laboratory services in tuberculosis control. WHO\/TB\/98.258."},{"issue":"11","key":"key-10.2471\/BLT.13.126532-201410241033-R15","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1128\/JCM.37.11.3693-3697.1999","article-title":"Simple and rapid identification of the Mycobacterium tuberculosis complex by immunochromatographic assay using anti-MPB64 monoclonal antibodies.","volume":"37","author":"Abe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"key-10.2471\/BLT.13.126532-201410241033-R16","author":"Kent","year":"1985","journal-title":"Public health mycobacteriology. A guide for the level III laboratory."},{"issue":"1","key":"key-10.2471\/BLT.13.126532-201410241033-R17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2334-5-62","article-title":"A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.","volume":"5","author":"Morgan","year":"2005","journal-title":"BMC Infect Dis"},{"issue":"1","key":"key-10.2471\/BLT.13.126532-201410241033-R18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1128\/JCM.37.1.45-48.1999","article-title":"Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.","volume":"37","author":"R\u00fcsch-Gerdes","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"10","key":"key-10.2471\/BLT.13.126532-201410241033-R19","first-page":"887","article-title":"Determinants of drug-resistant tuberculosis: analysis of 11 countries.","volume":"5","author":"Espinal","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.2471\/BLT.13.126532-201410241033-R20","unstructured":"Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. Geneva: World Health Organization; 2009. Available from: http:\/\/whqlibdoc.who.int\/publications\/2009\/9789241598675_eng.pdf [cited 2014 Aug 26]."},{"key":"key-10.2471\/BLT.13.126532-201410241033-R21","unstructured":"Global Tuberculosis Report 2013. WHO\/HTM\/TB\/2013.11. Geneva: World Health Organization; 2013. Available from http:\/\/apps.who.int\/iris\/bitstream\/10665\/91355\/1\/9789241564656_eng.pdf [cited 2014 Aug 26]."},{"issue":"5","key":"key-10.2471\/BLT.13.126532-201410241033-R22","doi-asserted-by":"publisher","first-page":"e5561","DOI":"10.1371\/journal.pone.0005561","article-title":"Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review.","volume":"4","author":"Suchindran","year":"2009","journal-title":"PLoS ONE"},{"issue":"1","key":"key-10.2471\/BLT.13.126532-201410241033-R23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1183\/09031936.00205413","article-title":"HIV and multidrug-resistant tuberculosis: overlapping epidemics.","volume":"44","author":"Dean","year":"2014","journal-title":"Eur Respir J"},{"issue":"12","key":"key-10.2471\/BLT.13.126532-201410241033-R24","doi-asserted-by":"publisher","first-page":"e15735","DOI":"10.1371\/journal.pone.0015735","article-title":"Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.","volume":"5","author":"Andrews","year":"2010","journal-title":"PLoS ONE"},{"issue":"11","key":"key-10.2471\/BLT.13.126532-201410241033-R25","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1086\/517536","article-title":"Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.","volume":"44","author":"Cox","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"11","key":"key-10.2471\/BLT.13.126532-201410241033-R26","doi-asserted-by":"publisher","first-page":"e7954","DOI":"10.1371\/journal.pone.0007954","article-title":"Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis.","volume":"4","author":"Matthys","year":"2009","journal-title":"PLoS ONE"},{"issue":"7","key":"key-10.2471\/BLT.13.126532-201410241033-R27","first-page":"607","article-title":"Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatment.","volume":"7","author":"Espinal","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"key-10.2471\/BLT.13.126532-201410241033-R28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/MJT.0b013e3181dd60ec","article-title":"Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.","volume":"18","author":"Tabarsi","year":"2011","journal-title":"Am J Ther"}],"container-title":["Bulletin of the World Health Organization"],"original-title":[],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:13:06Z","timestamp":1742404386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4221759\/pdf\/BLT.13.126532.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,18]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,9,18]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.2471\/blt.13.126532","relation":{},"ISSN":["0042-9686"],"issn-type":[{"value":"0042-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,18]]}}}